Adcock Ingram, a SouthAfrican pharmaceutical company, on Thursday received non-binding proposals for potential transaction to acquire 100% of, or a controlling interest in the company’s securities.Interestingly, none of the proposals are from Bidvest, ...
[Published Africa Investor - May 10 2013]